Published in Arch Dis Child on October 01, 1996
An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med (2011) 5.53
Primary ciliary dyskinesia: current state of the art. Arch Dis Child (2007) 2.51
Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Thorax (2005) 2.39
Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child (1998) 1.76
Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest (1998) 1.71
Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc Am Thorac Soc (2007) 1.49
Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance. Thorax (2002) 1.49
Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax (1998) 1.34
Primary ciliary dyskinesia: improving the diagnostic approach. Curr Opin Pediatr (2009) 1.21
The challenges of diagnosing primary ciliary dyskinesia. Proc Am Thorac Soc (2011) 1.16
Evidence that CFTR is expressed in rat tracheal smooth muscle cells and contributes to bronchodilation. Respir Res (2006) 1.15
Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis. Thorax (1998) 1.04
Chronic pancreatitis and cystic fibrosis. Gut (2003) 0.98
"CF asthma": what is it and what do we do about it? Thorax (2002) 0.97
Increased carbon monoxide in exhaled air of patients with cystic fibrosis. Thorax (1999) 0.94
Nasal nitric oxide in man. Thorax (1999) 0.94
Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review. Pediatr Pulmonol (2015) 0.91
Quantitative analysis of ciliary beating in primary ciliary dyskinesia: a pilot study. Orphanet J Rare Dis (2012) 0.91
Disease modifying genes in cystic fibrosis: therapeutic option or one-way road? Naunyn Schmiedebergs Arch Pharmacol (2006) 0.87
Antibiotic and anti-inflammatory therapies for cystic fibrosis. Cold Spring Harb Perspect Med (2013) 0.84
Interferon γ stimulates accumulation of gas phase nitric oxide in differentiated cultures of normal and cystic fibrosis airway epithelial cells. Lung (2012) 0.83
Extended nitric oxide measurements in exhaled air of cystic fibrosis and healthy adults. Lung (2009) 0.83
Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers. PLoS One (2013) 0.82
Exhaled nitric oxide in diagnosis and management of respiratory diseases. Ann Thorac Med (2009) 0.81
The role of inhaled corticosteroids in the management of cystic fibrosis. Paediatr Drugs (2009) 0.80
Application of nitric oxide measurements in clinical conditions beyond asthma. Eur Clin Respir J (2015) 0.80
Ventilatory pattern and energy expenditure are altered in cystic fibrosis mice. J Cyst Fibros (2013) 0.80
Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis. Thorax (2006) 0.78
Potential of anti-inflammatory treatment for cystic fibrosis lung disease. J Inflamm Res (2010) 0.78
Deciphering miRNA transcription factor feed-forward loops to identify drug repurposing candidates for cystic fibrosis. Genome Med (2014) 0.77
Assessment of airway inflammation with exhaled NO measurement. Hippokratia (2007) 0.77
Clinical value of measurement of pulmonary radioaerosol mucociliary clearance in the work up of primary ciliary dyskinesia. EJNMMI Res (2015) 0.75
Electronic Noses for Well-Being: Breath Analysis and Energy Expenditure. Sensors (Basel) (2016) 0.75
Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev (1991) 42.38
Increased nitric oxide in exhaled air of asthmatic patients. Lancet (1994) 5.39
Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med (1995) 4.82
Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science (1993) 4.80
Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J (1993) 3.29
Induction of nitric oxide synthase in asthma. Lancet (1994) 2.93
The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med (1994) 2.90
Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun (1991) 2.79
Lung function in white children aged 4 to 19 years: I--Spirometry. Thorax (1993) 2.52
Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J Clin Invest (1993) 2.42
Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med (1996) 2.32
Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun (1993) 2.14
The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol (1995) 2.12
Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis. Arch Dis Child (1993) 1.94
High nitric oxide production in human paranasal sinuses. Nat Med (1995) 1.90
Nitric oxide and lung disease. Thorax (1993) 1.77
A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr (1995) 1.75
Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur Respir J (1994) 1.69
Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med (1995) 1.67
Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference. J Pediatr (1994) 1.52
Nitric oxide is inactivated by the bacterial pigment pyocyanin. Biochem J (1990) 1.29
Effects of nitric oxide and nitrogen dioxide on bacterial growth. Appl Environ Microbiol (1983) 1.23
Nitric oxide is present in exhaled breath in humans: direct GC-MS confirmation. Biochem Biophys Res Commun (1994) 1.20
Impact of sinusitis in cystic fibrosis. J Allergy Clin Immunol (1992) 1.01
Nitric oxide synthase activity is elevated in inflammatory lung disease in humans. Eur J Pharmacol (1995) 0.95
Role of corticosteroids in cystic fibrosis lung disease. J R Soc Med (1996) 0.83
Milk antigen absorption in the preterm and term neonate. Arch Dis Child (1982) 2.02
A step in the right direction: assessing exercise tolerance in cystic fibrosis. Pediatr Pulmonol (1998) 1.77
Hemorrhagic shock and encephalopathy: clinical, pathologic, and biochemical features. J Pediatr (1989) 1.50
Recognition and early management of Reye's syndrome. Arch Dis Child (1986) 1.48
Haemorrhagic shock and encephalopathy: a new syndrome with a high mortality in young children. Lancet (1983) 1.46
Growth and lung function in Asian patients with cystic fibrosis. Arch Dis Child (2005) 1.43
A ten year review of colomycin. Respir Med (2000) 1.40
Monitoring in non-traumatic coma. Part I: Invasive intracranial measurements. Arch Dis Child (1988) 1.37
Testing carrier status in siblings of patients with cystic fibrosis. Arch Dis Child (1995) 1.23
Disordered breathing during sleep in patients with mucopolysaccharidoses. Int J Pediatr Otorhinolaryngol (2001) 1.21
Temporary inhibition of growth and adrenal suppression associated with the use of steroid nose drops. Eur J Pediatr (1994) 1.21
Survival rates in cystic fibrosis. Arch Dis Child (1983) 1.20
A distinctive type of hypohidrotic ectodermal dysplasia featuring hypothyroidism. J Pediatr (1986) 1.13
Nasopharyngeal airways in Pierre Robin Syndrome. J Pediatr (1982) 1.12
Quality of survival after artificial ventilation of the newborn. Arch Dis Child (1974) 1.12
Relationship of intraesophageal pressure to intrapleural pressure in the newborn. J Appl Physiol (1972) 1.12
Dornase alfa for cystic fibrosis. Patients should not be denied a safe, effective treatment. BMJ (1995) 1.02
The use of nasal continuous positive airway pressure to treat obstructive sleep apnoea. Arch Dis Child (2002) 1.02
Plasma terbutaline levels in asthma. Arch Dis Child (1983) 0.97
Fibrosing alveolitis and desquamative interstitial pneumonitis. Pediatr Pulmonol (1994) 0.97
Treatment of pleural empyema. J Paediatr Child Health (2000) 0.97
Cleft palate and accessory metacarpal of index finger syndrome: possible familial occurrence. J Med Genet (1978) 0.96
Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis. Arch Dis Child (1997) 0.93
Pulmonary hypertension in the perinatal aspiration syndromes. Pediatrics (1977) 0.92
Pulmonary artery sling in identical twins--report of two cases. Thorac Cardiovasc Surg (1984) 0.91
Foregut duplication cysts: a diagnostic challenge. J R Soc Med (1993) 0.91
The measurement of effective pulmonary capillary blood flow in the newborn, using low concentrations of nitrous oxide. Biol Neonate (1972) 0.91
Mycoplasma hominis. A cause of neonatal meningitis. Arch Dis Child (1979) 0.87
Tracheal extubation of the neonate at 2 to 3 cm H2O continuous positive airway pressure. Pediatrics (1977) 0.87
Pulmonary alveolar microlithiasis in childhood: diagnosis by transbronchial biopsy. Pediatr Pulmonol (1996) 0.87
Distinct patterns of respiratory difficulty in young children with achondroplasia: a clinical, sleep, and lung function study. Arch Dis Child (1998) 0.87
The relative importance of socio-economic status, parental smoking and air pollution (SO2) on asthma symptoms, spirometry and bronchodilator response in 11-year-old children. Pediatr Allergy Immunol (1999) 0.84
Annual review or continuous assessment? J R Soc Med (1996) 0.84
Generalized lymphangiomatosis and chylothorax in the pediatric age group. Pediatr Pulmonol (1992) 0.83
Pseudo-Bartter's syndrome in cystic fibrosis. Arch Dis Child (1990) 0.83
The effects of feeding on arterial blood gases and lung mechanics in newborn infants recovering from respiratory disease. J Pediatr (1977) 0.83
Role of corticosteroids in cystic fibrosis lung disease. J R Soc Med (1996) 0.83
Cardiopulmonary changes in the crying neonate. Pediatr Res (1979) 0.83
The Chrispin-Norman score in cystic fibrosis: doing away with the lateral view. Eur Respir J (2005) 0.83
Bronchial hyperresponsiveness in children with atopic dermatitis. Pediatrics (1993) 0.82
Management of the chest in cystic fibrosis. J R Soc Med (1986) 0.82
Exercise tolerance in children with cystic fibrosis undergoing lung transplantation assessment. Eur Respir J (2001) 0.81
Survey of criteria used to diagnose allergic bronchopulmonary aspergillosis in cystic fibrosis. Arch Dis Child (2001) 0.80
Primary pulmonary lymphangiectasis in a premature infant: resolution following intensive care. Pediatr Pulmonol (2003) 0.79
Why do viruses make infants wheeze? Arch Dis Child (1996) 0.79
Interstitial lung disease in children: a multicentre survey on diagnostic approach. Eur Respir J (2000) 0.78
High dose Nutrizym 22 in cystic fibrosis. Eur J Pediatr (1993) 0.78
The Young Everest Study: effects of hypoxia at high altitude on cardiorespiratory function and general well-being in healthy children. Arch Dis Child (2009) 0.78
Oxygen saturation in cystic fibrosis. Arch Dis Child (1991) 0.78
Standardizing lung function laboratories for multicenter trials. Pediatr Pulmonol (2007) 0.78
Desquamative interstitial pneumonia and antigen-antibody complexes in two infants with congenital rubella. Pediatrics (1983) 0.77
The effects of crying on arterial oxygen tension in infants recovering from respiratory distress. Crit Care Med (1979) 0.76
A baby with cough and poor feeding. Localised persistent pulmonary interstitial emphysema of the left lung. Eur Respir J (2003) 0.75
Ondine's curse: a new association. J R Soc Med (1989) 0.75
Artificial grunting in respiratory distress syndrome. Arch Dis Child (1972) 0.75
Treatment of acute asthma in children. Which approach is best? Allergol Immunopathol (Madr) (2008) 0.75
Children in a persistent vegetative state. Br Med J (Clin Res Ed) (1984) 0.75
Proceedings: Antenatal tests of pulmonary maturity and pulmonary function after birth. Arch Dis Child (1974) 0.75
Hypoglycaemia and Golytely in distal intestinal obstruction syndrome. J R Soc Med (1994) 0.75
Shake test on amniotic fluid and the respiratory distress syndrome. Br Med J (1973) 0.75
Pulmonary function in the infant of the diabetic mother. Arch Dis Child (1973) 0.75
Monitoring and treatment of raised intracranial pressure in children. J R Soc Med (1985) 0.75
Carrier testing in children for cystic fibrosis. BMJ (1995) 0.75
Pulmonary blood flow in the newborn. Arch Dis Child (1972) 0.75
The chest in cystic fibrosis. Practitioner (1980) 0.75
The baby's needs. Nursing (Lond) (1981) 0.75
Unusual gamma-glutamyltransferase isoenzyme pattern in serum in cystic fibrosis. Clin Chem (1985) 0.75
Letter: Pulmonary mechanics and blood-flow in the newborn. Lancet (1974) 0.75
Blood glucose concentration in heavy-for-date infants. J Perinat Med (1983) 0.75
Pulmonary blood flow in newborn. Arch Dis Child (1972) 0.75
Successful surgical treatment of tracheal compression following right pneumonectomy in infancy. Long-term follow-up. Eur J Cardiothorac Surg (1990) 0.75
Normal development from birth to 18 months. Nursing (Lond) (1981) 0.75
Cardiac defects in the Hallerman-Streiff syndrome. J Pediatr (1978) 0.75
Lung involvement in the multisystem syndrome CHARGE association. Eur Respir J (1997) 0.75
Respiratory syncytial virus infection causing neurological disorder in neonates. Lancet (1981) 0.75
Proceedings: Effective pulmonary capillary blood flow in infants without respiratory distress. Anaesthesia (1975) 0.75
The role of the laboratory in the diagnosis of cystic fibrosis. Clin Biochem (1984) 0.75
Proceedings: Physical and mental development after severe neonatal respiratory failure. Arch Dis Child (1974) 0.75
Chest physiotherapy during anesthesia for children with cystic fibrosis: effects on respiratory function. Pediatr Pulmonol (2007) 0.75
Measurement of intrathoracic pressure in the newborn. Arch Dis Child (1973) 0.75
Palmitic acid concentrations and lecithin/sphingomyelin ratios in amniotic fluid. Clin Chim Acta (1975) 0.75